Japanese encephalitis (JE)
Japanese encephalitis (JE), the leading cause of viral encephalitis in Asia, causes an estimated 30,000 to 50,000 cases and 10,000 to 15,000 deaths each year, mostly among children under 15 years of age. There is no specific treatment for JE. Vaccination is the single most important measure for controlling the disease.
More about JE | View resources on JE
Key resources
Weekly Epidemiological Record: Japanese Encephalitis Vaccines - WHO Position Paper (2006)
An article that provides background information on JE disease and vaccines, as well as the official World Health Organization (WHO) position on the use of JE vaccines in the global context.
A Cohort Study to Assess the New WHO Japanese Encephalitis Surveillance Standards (2008)
An
evaluation of the clinical case definition of acute encephalitis syndrome, which the standards use for identification of JE patients, to determine its sensitivity and specificity.
Current Use and Development of Vaccines for Japanese Encephalitis (2008)
A literature review analyzing the use of current JE vaccines and development of alternative vaccine candidates.
Featured PATH resources
Japanese Encephalitis Morbidity, Mortality, and Disability: Reduction and Control by 2015 (2009)
A
strategic plan that provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis control.
JE Vaccines at a Glance (2008)
A side-by-side comparison of internationally available JE vaccines, including information on dosage, cost, and supply.
Japanese Encephalitis Vaccine Introduction: A 1-Day Training Program (2008)
A lesson plan that maps a one-day vaccine introduction training program using existing PATH materials on the SA 14-14-2 JE vaccine, including information on the disease, as well as the vaccine.
Page last updated: August 2009.
